Lymphomas
First-in-Human Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of the BTK Degrader, ABBV-101, in Participants with B-cell Malignancies (M23-647)
- Details
ClinicalTrials.gov ID:
NCT05753501
Diagnosis Type:
NA
USOR Number:
- Address
1700 S Potomac Street
Aurora, CO 80012
P: (303) 418-7659